Evaluación de cobertura y del nivel de información en la campaña de vacunación contra la fiebre amarilla, Cusco,Perú, 2005
- Pablo F. Grajeda Ancca 1
- Carmen R. Rojas Pariona 2
- Henry Farfán Ríos 3
- Karina Huamán Condori 3
- Oscar Quispe Sanchez 3
- Marco Huaranca Delgado 3
- 1 Universidad Nacional San Antonio Abad del Cusco Facultad de Medicina
- 2 Field Epidemiology Training Program
- 3 UNSAAC Facultad de Medicina Humana
ISSN: 1018-8800, 1728-5917
Ano de publicación: 2008
Volume: 25
Número: 2
Páxinas: 63-67
Tipo: Artigo
Outras publicacións en: Acta Médica Peruana
Resumo
Introduction: Yellow Fever (YF) is enzootic in Cusco, and it is a serious public health problem. A National Plan for Control and Prevention of YF was implemented, aiming at vaccinating the whole Peruvian population above 1 year of age in four stages (2004-2007); and it was expected to vaccinate all of Cusco city inhabitants (306,160 persons in this age group) between November 2004 and February 2005. The final coverage reported was 83.5%. The objective of the study was to assess vaccination coverage and knowledge and communication levels of this campaign. Methods: A descriptive, cross-sectional, and prospective study was performed in Cusco in March 2005, using a stratified and randomized sampling technique. 954 people were interviewed in order to assess vaccination coverage and 386 for other objective measures. Results: Vaccination coverage against yellow fever in Cusco was 64.04%. Vaccinated people did not have good knowledge of: what yellow fever is (76.7%), how is it transmitted (50.9%), time in which the vaccine starts to exert its effect (84.9%), duration of the protective effect of the vaccine (92.2%), and contraindications for vaccination (65.2%). Only 0.27% remembered at least one of key messages of the campaign. Conclusions: This assessment showed that the goals for coverage in this vaccination campaign were not achieved; there were large differences between official reports (83.5%) and the results form our survey (64.04%). Immunized population was not adequately informed about the yellow fever vaccine and its vaccination campaign, which leads to question the benefits of performing campaigns affecting some basic bioethical principles.